[HTML][HTML] Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field …

E Di Maria, A Latini, P Borgiani, G Novelli - Human genomics, 2020 - Springer
The COVID-19 pandemic has strengthened the interest in the biological mechanisms underlying
the complex interplay between infectious agents and the human host. The spectrum of …

[HTML][HTML] Genetic factors in systemic lupus erythematosus: contribution to disease phenotype

F Ceccarelli, C Perricone, P Borgiani… - Journal of immunology …, 2015 - hindawi.com
Genetic factors exert an important role in determining Systemic Lupus Erythematosus (SLE)
susceptibility, interplaying with environmental factors. Several genetic studies in various SLE …

[HTML][HTML] Age-related macular degeneration: insights into inflammatory genes

…, C Strafella, F Missiroli, P Borgiani… - Journal of …, 2014 - hindawi.com
Age-related macular degeneration (AMD) is a progressive neurodegenerative disease that
affects approximately 8.7% of elderly people worldwide (>55 years old). AMD is …

[HTML][HTML] COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells

A Latini, E Agolini, A Novelli, P Borgiani, R Giannini… - Genes, 2020 - mdpi.com
The recent global COVID-19 public health emergency is caused by SARS-CoV-2 infections
and can manifest extremely variable clinical symptoms. Host human genetic variability could …

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

P Borgiani, C Ciccacci, V Forte, E Sirianni, L Novelli… - 2009 - Future Medicine
Introduction: It is known that warfarin treatment is problematic, due to its narrow therapeutic
range and to the great interindividual variability. Numerous papers have shown the important …

[HTML][HTML] A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics

…, I Balogh, N Başak, R Böhm, J Borg, P Borgiani… - PloS one, 2016 - journals.plos.org
Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity
with the underlying genetic composition, particularly in genes encoding for protein factors …

[HTML][HTML] Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients

A Novelli, M Biancolella, P Borgiani, D Cocciadiferro… - Human genomics, 2020 - Springer
Background Coronaviruses (CoV) are a large family of viruses that are common in humans
and many animal species. Animal coronaviruses rarely infect humans with the exceptions of …

[HTML][HTML] Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications

…, A Termine, S Barati, S Gambardella, P Borgiani… - Genes, 2020 - mdpi.com
Angiotensin-converting enzyme 2 (ACE2) has been recognized as the entry receptor of the
novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Structural and …

[HTML][HTML] Genetic tests and genomic biomarkers: regulation, qualification and validation

G Novelli, C Ciccacci, P Borgiani… - Clinical cases in …, 2008 - ncbi.nlm.nih.gov
The identification of new risk factors for specific diseases is an enduring theme in medical
research. Advances in molecular biology, genetics, and computational biology are …

Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes

…, G Novelli, F Sangiuolo, GA Marfia, P Borgiani… - Acta Diabetologica, 2014 - Springer
Diabetic polyneuropathy (DPN) and cardiovascular autonomic neuropathy (CAN) are common
type 2 diabetes complications with a large inter-individual variability in terms of clinical …